
Purebect CS 500mg/500mg Injection
Marketer
Puremed Biotech
Salt Composition
Cefoperazone (500mg) + Sulbactam (500mg)
Overview Purebect CS 500mg/500mg Injection
Combiflox 500mg/500mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus curbing infection spread. Administration must be solely under a physician's guidance. Complete the prescribed regimen; premature cessation can compromise effectiveness. Regularly scheduled doses are crucial. Typical mild reactions include nausea, vomiting, diarrhea, and dyspepsia; severe reactions necessitate immediate medical attention. Allergic responses (e.g., rash, pruritus, edema, dyspnea) demand prompt medical care. Disclose all current medications to your doctor before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and ample hydration facilitate recovery. Monitoring via laboratory tests may be implemented to assess treatment efficacy.
Uses of Purebect CS 500mg/500mg Injection
Managing Bacterial Infections
Major Benefits of Purebect CS 500mg/500mg Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Purebect CS 500mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Purebect CS 500mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Purebect CS 500mg/500mg Injection works:
Purebect CS 500mg/500mg Injection combines the antibiotic Cefoperazone with the beta-lactamase inhibitor Sulbactam. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam counters bacterial resistance mechanisms, thus boosting Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during Purebect CS 500mg/500mg Injection treatment can result in adverse effects including facial redness, tachycardia, queasiness, dehydration, pectoral pain, and hypotension (a disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
Administering Purebect CS 500mg/500mg Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Purebect CS 500mg/500mg Injection is considered safe for breastfeeding mothers. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Purebect CS 500mg/500mg Injection on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Purebect CS 500mg/500mg Injection to individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Purebect CS 500mg/500mg Injection to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Purebect CS 500mg/500mg Injection :
Omit a Purebect CS 500mg/500mg Injection dose? Seek medical advice immediately.
Facts to Know About Purebect CS 500mg/500mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Infectious Disease Treatments |
